Showing results (791-800 of 944) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|February 2, 2022
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentRobert A Hauser, Antonella Favit, L Arthur Hewitt, et al.
Neurology and Therapy|April 26, 2022
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, et al.
Neurology and Therapy|March 23, 2022
Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's ReviewGavin Giovannoni, Joela Mathews
Neurology and Therapy|April 20, 2022
Comparative Effectiveness of Carbidopa-Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson's Disease-Related Pill Burden Reduction in Advanced Parkinson's Disease: A Retrospective Real-World Cohort StudyMichael J Soileau, Fernando Pagan, Alfonso Fasano, et al.
Neurology and Therapy|April 20, 2022
Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature ReviewJuliette C Thompson, François-Xavier Chalet, Eric J Manalastas, et al.
Neurology and Therapy|May 18, 2019
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli StudyCharlotte Lawthom, Pedro Bermejo, Dulce Campos, et al.
Neurology and Therapy|May 18, 2019
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with SchizophreniaAfzal Javed, Holger Arthur, Logos Curtis, et al.
Neurology and Therapy|July 7, 2019
Case Report of a Novel Technique for Repair of the Vertebral Artery During Cranial SurgeryManjunath Prasad, Nitin Mukerji
Neurology and Therapy|March 14, 2022
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with OfatumumabAnne H Cross, Silvia Delgado, Mario Habek, et al.
Neurology and Therapy|July 6, 2019
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease ProgressionJeri Burtchell, Kristen Fetty, Katelyn Miller, et al.
Pageof 95